mortality/aging
• mice die in utero as no homozygous pups are seen
|
Allele Symbol Allele Name Allele ID |
Htttm5Detl targeted mutation 5, Peter J Detloff MGI:6400708 |
||||||||||||
Summary |
2 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• mice die in utero as no homozygous pups are seen
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
N |
• mice do not exhibit signs of tremor, hunching, unsteady movements or staggering gait up to 70 weeks of age and do not exhibit spontaneous or handling-induced seizures
|
• males, but not females, exhibit enhanced fast motor learning (performance on the rotarod across all 3 testing days) at 40 and 60 weeks of age
|
• females, but not males, spend increased time along the walls of the test chamber, indicating increased thigmotaxis and possible anxiety
|
• at 60 weeks of age, males, but not females, show a reduction in motor coordination on the 2nd and 3rd days of testing on the accelerating rotarod, with a shorter latency to fal
|
• males and females exhibit reduced grip strength, with a significant decrease in females at 50 weeks of age
|
• females spend more time with their bodies contracted, or hunched, at nearly all ages
|
• females, but not males, show a reduction in hind paw step cycle
• males, but not females, show a reduction in front paw base of support at 60 weeks of age, indicating reduced stability
|
• males, but not females, show an increase in front paw stride length
|
• mice exhibit an overall decrease in spontaneous locomotion during the active dark phase, with females being more severely affected than males at 70 weeks of age
• however, no differences in spontaneous activity during the light phase are seen
|
• mice show reduced weight by 70 weeks of age
• males exhibit a 9.4% reduced body weight by 40 weeks of age while females exhibit a 9.4% reduced body weight by 30 weeks of age
|
• fewer than the expected number of pups are seen, indicating reduced viability
|
• females, but not males, show a reduction in striatal DARPP-32 (a neuropathological maker of Huntingtons Disease pathogenesis) expression with no cell loss
• however, no differences in synaptophysin or CB1 receptor expression in the striatum are seen
• Htt aggregates are seen in the striatum, at similar levels in males and females
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Huntington's disease | DOID:12858 |
OMIM:143100 |
J:250587 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|